Cargando…
Physiologically Based Pharmacokinetic Model To Predict Metoprolol Disposition in Healthy and Disease Populations
[Image: see text] The evolution in the development of drugs has increased the popularity of physiologically based pharmacokinetic (PBPK) models. This study seeks to assess the PK of metoprolol in populations with healthy, chronic kidney disease (CKD), and acute myocardial infarction (AMI) conditions...
Autores principales: | Zamir, Ammara, Rasool, Muhammad Fawad, Imran, Imran, Saeed, Hamid, Khalid, Sundus, Majeed, Abdul, Rehman, Anees Ur, Ahmad, Tanveer, Alasmari, Fawaz, Alqahtani, Faleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433471/ https://www.ncbi.nlm.nih.gov/pubmed/37599939 http://dx.doi.org/10.1021/acsomega.3c02673 |
Ejemplares similares
-
A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
por: Khalid, Sundus, et al.
Publicado: (2021) -
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
por: Khalid, Sundus, et al.
Publicado: (2023) -
A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
por: Talha Zahid, Muhammad, et al.
Publicado: (2023) -
Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations
por: Hafsa, Hafsa, et al.
Publicado: (2022) -
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
por: Rasool, Muhammad F., et al.
Publicado: (2021)